Genomic ancestry as a predictor of haemodynamic profile in heart failure
Carregando...
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMJ PUBLISHING GROUP
Citação
OPEN HEART, v.3, n.2, article ID UNSP e000434, 9p, 2016
Resumo
Objective: The aim of this study is to assess the association between genetic ancestry, self-declared race and haemodynamic parameters in patients with chronic heart failure (HF). Methods: Observational, cross-sectional study. Eligible participants were aged between 18 and 80 years; ejection fraction was <= 50%. Patients underwent genetic analysis of ancestry informative markers, echocardiography and impedance cardiography (ICG). Race was determined by self-classification into two groups: white and non-white. Genomic ancestry was estimated using a panel of 101 348 polymorphic markers and three continental reference populations (European, African and Native American). Results: Our study included 362 patients with HF between August 2012 and August 2014. 123 patients with HF declared themselves as white and 234 patients declared themselves as non-white. No statistically significant differences were found regarding the ICG parameters according to self-declared race. The Amerindian ancestry was positively correlated with systolic time ratio (r=0.109, p<0.05). The thoracic fluid content index (r=0.124. p<0.05), E wave peak (r=0.127. p<0.05) and E/e' ratio (r=0.197. p<0.01) were correlated positively with African ancestry. In multiple linear regression, African ancestry remained associated with the E/e0 ratio, even after adjustment to risk factors. Conclusions: The African genetic ancestry was associated with worse parameters of diastolic function; the Amerindian ancestry correlated with a worse pattern of ventricular contractility, while self-declared colour was not helpful to infer haemodynamic profiles in HF.
Palavras-chave
Referências
- Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
- ALEXANDER M, 1995, JAMA-J AM MED ASSOC, V274, P1037, DOI 10.1001/jama.274.13.1037
- Alexander M, 1999, AM HEART J, V137, P919, DOI 10.1016/S0002-8703(99)70417-5
- Bernardez-Pereira S, 2014, BMC CARDIOVASC DISOR, V14, DOI [10.1186/1471-2261-14-32, 10.1186/1471-2261-14-90]
- Cardena MMSG, 2014, INT J CARDIOL, V176, P527, DOI 10.1016/j.ijcard.2014.07.039
- Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005
- Castellanos LR, 2009, J CARD FAIL, V15, P41, DOI 10.1016/j.cardfail.2008.09.003
- Charron P, 2001, EUR J PHARMACOL, V417, P1, DOI 10.1016/S0014-2999(01)00878-0
- Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a
- Flack JM, 2011, AM J CARDIOVASC DRUG, V11, P83, DOI 10.2165/11586930-000000000-00000
- Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038
- Ginsburg GS, 2007, J AM COLL CARDIOL, V50, P930, DOI 10.1016/j.jacc.2007.05.025
- Harjai KJ, 2002, CLIN CARDIOL, V25, P479, DOI 10.1002/clc.4960251008
- Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
- Hebbar S, 1999, NEW ENGL J MED, V341, P288
- *IBGE, CENS DEM 2000 CAR GE
- Joffe Samuel W, 2013, J Clin Med Res, V5, P194, DOI 10.4021/jocmr1376w
- Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
- Kurnik D, 2008, PHARMACOGENET GENOM, V18, P895, DOI 10.1097/FPC.0b013e328309733f
- Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812
- Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277
- Parrott Charles W, 2004, Congest Heart Fail, V10, P11, DOI 10.1111/j.1527-5299.2004.03407.x
- Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
- Pereira SB, 2013, MOL MED REP, V7, P259, DOI 10.3892/mmr.2012.1120
- Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
- Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517
- Russo C, 2010, AM HEART J, V160, P152, DOI 10.1016/j.ahj.2010.04.010
- Sharp A, 2008, J AM COLL CARDIOL, V52, P1015
- SHG C, HUMAN GENOME DIVERSI
- Taylor MR, 2014, JACC-HEART FAIL, V2, P561, DOI 10.1016/j.jchf.2014.06.010
- Thompson Brenda, 2008, Congest Heart Fail, V14, P261, DOI 10.1111/j.1751-7133.2008.00001.x
- Xie HG, 2001, PHARMACOGENETICS, V11, P191, DOI 10.1097/00008571-200104000-00002
- Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803